Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Patent
1998-12-15
2000-10-24
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
424489, 424426, A61L 904, A61F 200, A61K 914
Patent
active
061362956
ABSTRACT:
Improved aerodynamically light particles for drug delivery to the pulmonary system, and methods for their synthesis and administration are provided. In a preferred embodiment, the aerodynamically light particles are made of a biodegradable material and have a tap density less than 0.4 g/cm.sup.3 and a mass mean diameter between 5 .mu.m and 30 .mu.m. The particles may be formed of biodegradable materials such as biodegradable polymers. For example, the particles may be formed of a functionalized polyester graft copolymer consisting of a linear .alpha.-hydroxy-acid polyester backbone having at least one amino acid group incorporated therein and at least one poly(amino acid) side chain extending from an amino acid group in the polyester backbone. In one embodiment, aerodynamically light particles having a large mean diameter, for example greater than 5 .mu.m, can be used for enhanced delivery of a therapeutic agent to the alveolar region of the lung. The aerodynamically light particles incorporating a therapeutic agent may be effectively aerosolized for administration to the respiratory tract to permit systemic or local delivery of wide variety of therapeutic agents.
REFERENCES:
patent: 2470296 (1949-05-01), Fields
patent: 2533065 (1950-03-01), Taplin et al.
patent: 2992645 (1961-07-01), Fowler
patent: 3781230 (1973-12-01), Vassiliades et al.
patent: 3957965 (1976-05-01), Hartley et al.
patent: 4009280 (1977-02-01), Macarthur et al.
patent: 4089800 (1978-05-01), Temple
patent: 4161516 (1979-07-01), Bell
patent: 4173488 (1979-11-01), Vassiliades et al.
patent: 4272398 (1981-06-01), Jaffe
patent: 4352883 (1982-10-01), Lim
patent: 4391909 (1983-07-01), Lim
patent: 4466442 (1984-08-01), Hilmann et al.
patent: 4524769 (1985-06-01), Wetterlin
patent: 4572203 (1986-02-01), Feinstein
patent: 4590206 (1986-05-01), Forrester et al.
patent: 4615697 (1986-10-01), Robinson
patent: 4679555 (1987-07-01), Sackner
patent: 4741872 (1988-05-01), De Luca et al.
patent: 4743545 (1988-05-01), Torobin
patent: 4774958 (1988-10-01), Feinstein
patent: 4789550 (1988-12-01), Hommel et al.
patent: 4818542 (1989-04-01), De Luca et al.
patent: 4847091 (1989-07-01), Illum
patent: 4855144 (1989-08-01), Leong et al.
patent: 4857311 (1989-08-01), Domb et al.
patent: 4861627 (1989-08-01), Mathiowitz et al.
patent: 4865789 (1989-09-01), Castro et al.
patent: 4904479 (1990-02-01), Illum
patent: 4917119 (1990-04-01), Potter et al.
patent: 4976968 (1990-12-01), Steiner
patent: 4994281 (1991-02-01), Muranishi et al.
patent: 5033463 (1991-07-01), Cocozza
patent: 5064650 (1991-11-01), Lew
patent: 5069936 (1991-12-01), Yen
patent: 5075109 (1991-12-01), Tice et al.
patent: 5100669 (1992-03-01), Hyon et al.
patent: 5123414 (1992-06-01), Unger
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5160745 (1992-11-01), De Luca et al.
patent: 5169871 (1992-12-01), Hughes et al.
patent: 5195520 (1993-03-01), Schlief et al.
patent: 5204108 (1993-04-01), Illum
patent: 5204113 (1993-04-01), Hartley et al.
patent: 5260306 (1993-11-01), Boardman et al.
patent: 5271961 (1993-12-01), Mathiowitz et al.
patent: 5306483 (1994-04-01), Mautone
patent: 5327883 (1994-07-01), Williams et al.
patent: 5334381 (1994-08-01), Unger
patent: 5352435 (1994-10-01), Unger
patent: 5384133 (1995-01-01), Boyes et al.
patent: 5393524 (1995-02-01), Quay
patent: 5407609 (1995-04-01), Tice et al.
patent: 5456917 (1995-10-01), Wise et al.
patent: 5482946 (1996-01-01), Clark et al.
patent: 5518709 (1996-05-01), Sutton et al.
patent: 5518998 (1996-05-01), Backstrom et al.
patent: 5551489 (1996-09-01), Trofast et al.
patent: 5607695 (1997-03-01), Ek et al.
patent: 5612053 (1997-03-01), Baichwal et al.
patent: 5674471 (1997-10-01), Akehurst et al.
patent: 5690954 (1997-11-01), Illum
patent: 5707644 (1998-01-01), Illum
patent: 5804212 (1998-09-01), Illum
patent: 5814607 (1998-09-01), Patton
patent: 5830853 (1998-11-01), Backstrom et al.
Adjei and Garren, "Pulmonary Delivery of Peptide Drugs: Effect of Particle Size on Bioavailability of Leuprolide Acetate in Healthy Male Volunteers," J. Pharm. Res., 7: 565-569 (1990).
Altschuler, et al., "Aerosol deposition in the human respiratory tract," Am. Med. Assoc. Arch. Indust. Health 15: 293-303 (1957).
Anderson, et al., "Effect of Cystic Fibrosis on Inhaled Aerosol Boluses," Am. Rev. Respir. Dis., 140: 1317-1324 (1989).
Barrera, et al., "Synthesis and RGD Peptide Modification of a New Biodegradable Copolymer: Poly(lactic acid-co-lysine)," J Am. Chem. Soc., 115: 11010 (1993).
Benita, et al., "Characterization of drug-loaded poly(d,I-lactide) microspheres," J. Pharm. Sci 73: 1721-1724 (1984).
Blackett and Buckton, "A Microcalorimetric Investigation of the Interaction of Surfactants with Crystalline and Partially Crystalline Salbutamol Sulphate in a Model Inhalation Aerosol System," Pharmaceutical Research 12(11): 1689-1693 (1995).
Brain, Physiology and Pathophysiology of Pulmonary Macrophages, in The Reticuloendothelial System, Reichard and Filkins, Eds., Plenum Press, New York, pp. 315-327 (1985).
Byron, "Determinants of drug and polypeptide bioavailability from aerosols delivered to the lung," Adv. Drug. Del. Rev., 5: 107-132 (1990).
Clark and Egan, "Modeling the deposition of inhaled powdered drug aerosols," J. Aerosol Sci., 25: 175-186 (1994).
Clay, et al. "Effect of aerosol particle size on bronchodilation with nebulized terbutaline in asthmatic subjects," Thorax 41: 364-368 (1986).
Cohen, et al., "Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres," Pharm. Res. 8(6): 713-720 (1991).
Colthorpe, et al., "The Pharmacokinetics of Pulmonary-Delivered Insulin: A Comparison of Intratracheals and Aerosol Administration to the Rabbit," Pharm. Res. 9: 764 (1992).
Daly, et al., "The Preparation of N-Carboxyanhydrides of .alpha.-Amino Acids Using Bis(Trichloromethyl) Carbonate," Tetrahedron Lett., 29: 5859 (1988).
Damms and Bains, "The Cost of Delivering Drugs Without Needles," J. Controlled Release, 8-11 (1996).
Davies, et al., "Breathing of half-micron aerosols. I. Experimental.," J. Appl. Physiol. 32: 591-600 (1972).
Dorries and Valberg, "Heterogeneity of phagocytosis for inhaled versus instilled material," Am. Rev. Resp. Disease, 146: 831-837 (1991).
Doubrow, Ed., "Microcapsules and Nanopartaicles in Medicine and Pharmacy," CRC Press, Boca Raton, 1992.
Edwards, "The macrotransport of aerosol particles in the lung: Aerosol deposition phenomena," J. Aerosol Sci., 26: 293-317 (1995).
Eldridge, et al., "Biodegradable microspheres as a vaccine delivery system," Mol. Immunol., 28: 287-294 (1991).
Findeisen, "Uber das Absetzen kleiner in der Luft suspendierter Teilchen in der menshlichen Lunge bei der Atmung," Pflugers Arch. D. Ges. Physiol. 236: 367-379 (1935).
French, Edwards, and Niven, "The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation," J. Aerosol Sci., 27: 769-783 (1996).
Ganderton, "The generation of respirable clouds from coarse powder aggregates," J. Biopharmaceutical Sciences, 3: 101-105 (1992).
Gehr, et al., "Surfactant and inhaled particles in the conducting airways: Structural, stereological, and biophysical aspects," Microscopy Res. And Tech., 26: 423-436 (1993).
Gerrity, et al., :Calculated deposition of inhaled particles in the airway generations of normal subjects, J. Appl. Phys., 47: 867-873 (1979).
Gonda, "Aerosols for delivery of therapeutic and diagnostic agents to the respiratory tract," in Critical Reviews in Therapeutic Drug Carrier Systems, 6: 273-313 (1990).
Gonda, "Preface. Major issues and future prospects in the delivery of therapeutic and diagnostic agents to the respiratory tract," Adv. Drug Del. Rev. 5: 1-9 (1990).
Gonda, "Physico-chemical principles in aerosol delivery," in Topics in Pharmaceutical Sciences 1991, Crommelin, D.J. and K.K. Midha, Eds., Medpharm Scientific Publishers, Stuttgart, pp. 95-117, 1992.
Gonda, "Targeting by deposition," in Pharmaceutical Inhalation Aersol Technology (ed. A.J. Hickey), Marcel Dekkar Inc., New York, 1992.
Heyder ,et al., "Mathematical Models of particle deposition in the
Ben-Jebria Abdell Aziz
Caponetti Giovanni
Edwards David A.
Hanes Justin
Hrkach Jeffrey S.
Howard S.
Massachusetts Institute of Technology
Page Thurman K.
Penn State Research Foundation
LandOfFree
Aerodynamically light particles for pulmonary drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aerodynamically light particles for pulmonary drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aerodynamically light particles for pulmonary drug delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960530